<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Syndromol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Syndromol</journal-id>
<journal-id journal-id-type="publisher-id">MSY</journal-id>
<journal-title-group>
<journal-title>Molecular Syndromology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1661-8769</issn>
<issn pub-type="epub">1661-8777</issn>
<publisher>
<publisher-name>S. Karger AG</publisher-name>
<publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27781027</article-id>
<article-id pub-id-type="pmc">5073622</article-id>
<article-id pub-id-type="doi">10.1159/000448530</article-id>
<article-id pub-id-type="publisher-id">msy-0007-0172</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Understanding Genotypes and Phenotypes in Epileptic Encephalopathies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Helbig</surname>
<given-names>Ingo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tayoun</surname>
<given-names>Abou Ahmad N.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>a</sup>Division of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pa., USA</aff>
<aff id="aff2"><sup>b</sup>Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pa., USA</aff>
<aff id="aff3"><sup>c</sup>Division of Department of Neuropediatrics, Christian Albrechts University of Kiel and University Medical Center Schleswig-Holstein (UKSH), Kiel, Germany</aff>
<author-notes>
<corresp id="cor1">*Ingo Helbig, The Children-s Hospital of Philadelphia, 34th Street and Civic Center Blvd, Philadelphia, PA 19104 (USA), E-Mail <email>helbigi @ email.chop.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>3</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>7</volume>
<issue>4</issue>
<fpage>172</fpage>
<lpage>181</lpage>
<permissions>
<copyright-statement>Copyright © 2016 by S. Karger AG, Basel</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Epileptic encephalopathies are severe often intractable seizure disorders where epileptiform abnormalities contribute to a progressive disturbance in brain function. Often, epileptic encephalopathies start in childhood and are accompanied by developmental delay and various neurological and non-neurological comorbidities. In recent years, this concept has become virtually synonymous with a group of severe childhood epilepsies including West syndrome, Lennox-Gastaut syndrome, Dravet syndrome, and several other severe childhood epilepsies for which genetic factors are increasingly recognized. In the last 5 years, the field has seen a virtual explosion of gene discovery, raising the number of bona fide genes and possible candidate genes for epileptic encephalopathies to more than 70 genes, explaining 20-25% of all cases with severe early-onset epilepsies that had otherwise no identifiable causes. This review will focus on the phenotypic variability as a characteristic aspect of genetic epilepsies. For many genetic epilepsies, the phenotypic presentation can be broad, even in patients with identical genetic alterations. Furthermore, patients with different genetic etiologies can have seemingly similar clinical presentations, such as in Dravet syndrome. While most patients carry mutations in <italic>SCN1A</italic>, similar phenotypes can be seen in patients with mutations in <italic>PCDH19</italic>, <italic>CHD2</italic>, <italic>SCN8A</italic>, or in rare cases <italic>GABRA1</italic> and <italic>STXBP1</italic>. In addition to the genotypic and phenotypic heterogeneity, both benign phenotypes and severe encephalopathies have been recognized in an increasing number of genetic epilepsies, raising the question whether these conditions represent a fluid continuum or distinct entities.</p>
</abstract>
<kwd-group>
<title>Key Words</title>
<kwd>Epileptic encephalopathy</kwd>
<kwd>Genotypic heterogeneity</kwd>
<kwd>Next-generation sequencing</kwd>
<kwd>Phenotypic heterogeneity</kwd>
<kwd>Whole-exome sequencing</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="3"></table-count>
<ref-count count="60"></ref-count>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>